{"id":531207,"date":"2021-02-22T17:22:01","date_gmt":"2021-02-22T17:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=531207"},"modified":"2021-02-22T17:22:01","modified_gmt":"2021-02-22T17:22:01","slug":"nextgeneration-biomanufacturing-market-with-industry-capacity-future-growth-research-methodology-and-forecast-to-2027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nextgeneration-biomanufacturing-market-with-industry-capacity-future-growth-research-methodology-and-forecast-to-2027_531207.html","title":{"rendered":"Next-Generation Biomanufacturing Market with Industry Capacity, Future Growth, Research Methodology and Forecast To 2027"},"content":{"rendered":"
Increase in the number of biopharmaceutical companies across the nations is the key reason driving the growth of next-generation biomanufacturing in global market.<\/p>\n<\/div>\n

The global next-generation biomanufacturing market<\/a> is expected to reach a market size of USD 39.18 Billion by 2028, according to a recent analysis by Emergen Research. Next-generation biomanufacturing process makes it possible to meet increasing demand for biological medicine used in the treatment of critical diseases such as liver and kidney disorders, cancer and diabetes.<\/p>\n

In addition, growing adoption of single-use products such as single-use bio-reactors, bio containers and increasing financial support from private investors and governments for development of next-generation biomanufacturing units are among some major factors driving growth of the global next-generation biomanufacturing market, and the trend is expected to continue over the forecast period.<\/p>\n

Get your Sample Copy with TOC of the Report to understand the structure of the complete report@ <\/strong>https:\/\/www.emergenresearch.com\/request-sample\/504<\/strong><\/a><\/p>\n

The prominent players of the global Next-Generation Biomanufacturing market are expected to contribute significantly to the revenue generation owing to increasing demand for the Next-Generation Biomanufacturing products in the industry.<\/p>\n

Key Players Participating in the Industry:<\/strong><\/p>\n

Merck KGaA, Thermo Fisher Scientific Inc., Eppendorf AG, Danaher Corporation, GEA Group Aktiengesellschaft, Sartorius AG, bbi-biotech GmbH, Solaris Biotechnology Srl, Esco Group of Companies, Pierre Guérin, and PBS Biotech, Inc.<\/p>\n

Furthermore, the report offers insights into the segmentation of the Next-Generation Biomanufacturing industry based on product types, applications, and key regions. The study also assesses the market segment expected to show significant growth in the coming years.<\/p>\n